Showing 2,825 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

PrEP policies & guidelines

US: State laws about prescribing may limit access to HIV pre-exposure prophylaxis

Editor's pick
EurekAlert
24 January 2022
PrEP programmes & uptake

Big increase in recent PrEP users among new HIV cases, largest UK clinic reports

News
24 January 2022
PrEP policies & guidelines

United States v. Gilead: Two Year Anniversary Letter

Editor's pick
PrEP4All
21 January 2022
PrEP programmes & uptake

Brazil: Stigma and a lack of HIV knowledge linked to low PrEP use

Editor's pick
Avert
20 January 2022
PrEP programmes & uptake

This HIV prevention medicine is for everyone. Why do so few people take it?

Editor's pick
STAT
20 January 2022
PrEP

What’s the difference between PrEP and PEP for HIV prevention?

About HIV
January 2022
Injectable & long-acting PrEP

Injectable PrEP and COVID show we’re all in this together

News
7 January 2022
PrEP programmes & uptake

Kenya: One-Stop Shop Model Benefits PrEP Delivery

Editor's pick
Contagion Live
3 January 2022
PrEP programmes & uptake

Lessons for Africa: Kenya’s PrEP integration in public clinics can inform scale-up in other countries

News
3 January 2022
HIV testing policies & guidelines

American Academy of Pediatrics Advises Universal, Routine HIV Screening in Teens and Biomedical HIV Prevention for Youth at Risk

Editor's pick
American Academy of Pediatrics
28 December 2021
Injectable & long-acting PrEP

Fair Pricing Coalition Welcomes Approval Of Two-Month HIV Prevention Shot; Denounces ViiV Healthcare’s Exorbitant, Unsustainable Pricing

Editor's pick
Fair Pricing Coalition
26 December 2021
Government, leadership & policy

US: 2021 Was a Year of HIV Progress; Now Let’s Focus on PrEP Access

Editor's pick
POZ
26 December 2021
Injectable & long-acting HIV treatment

Particulate problem prompts hold on 10 Gilead studies of HIV hopeful lenacapavir

Editor's pick
FiercePharma
26 December 2021
Injectable & long-acting PrEP

GlaxoSmithKline's HIV prevention injectable Apretude threatens Gilead with FDA blessing. But will doctors use it?

Editor's pick
FiercePharma
26 December 2021
Injectable & long-acting PrEP

US approves injectable cabotegravir for PrEP

News
24 December 2021
Injectable & long-acting PrEP

AVAC Applauds US FDA Approval of the First injectable Form of HIV Pre-exposure Prophylaxis

Editor's pick
AVAC
21 December 2021
Injectable & long-acting PrEP

FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention

Editor's pick
Food & Drug Administration
21 December 2021
New & experimental HIV treatments

Trials of long-acting islatravir for HIV treatment and prevention placed on hold

News
21 December 2021
PrEP policies & guidelines

UK: NICE recommends offering PrEP to people at high risk of HIV for first time

Editor's pick
National Institute for Health and Care Excellence (NICE)
17 December 2021
Injectable & long-acting HIV treatment

Merck Announces Clinical Holds on Studies Evaluating Islatravir for the Treatment and Prevention of HIV-1 Infection

Editor's pick
Merck press release
14 December 2021
Vaginal rings & topical PrEP

IPM Statement on US Food and Drug Administration Review of Dapivirine Vaginal Ring

Editor's pick
International Partnership for Microbicides
13 December 2021
Vaginal rings & topical PrEP

WHO continues to support its conditional recommendation for the dapivirine vaginal ring as an additional prevention option for women at substantial risk of HIV

Editor's pick
World Health Organization
13 December 2021
PrEP science

Landscape report launched on novel technologies for the prevention of HIV, STIs, and unwanted pregnancy

Editor's pick
Unitaid
10 December 2021
Injectable & long-acting HIV treatment

Long-Acting HIV Therapy Hits a Snag

Editor's pick
POZ
9 December 2021